[HTML][HTML] Macrophage-based combination therapies as a new strategy for cancer immunotherapy
L Tian, A Lei, T Tan, M Zhu, L Zhang, H Mou… - Kidney Diseases, 2022 - karger.com
Background: Cells of the immune system can inhibit tumor growth and progression;
however, immune cells can also promote tumor cell growth, survival, and angiogenesis as a …
however, immune cells can also promote tumor cell growth, survival, and angiogenesis as a …
Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy
L Tian, A Lei, T Tan, M Zhu, L Zhang… - Kidney diseases …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Cells of the immune system can inhibit tumor growth and progression; however,
immune cells can also promote tumor cell growth, survival, and angiogenesis as a result of …
immune cells can also promote tumor cell growth, survival, and angiogenesis as a result of …
[PDF][PDF] Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy
L Tiana, A Leia, T Tana, M Zhua, L Zhanga… - 2021 - scholar.archive.org
Background: Cells of the immune system can inhibit tumor growth and progression;
however, immune cells can also promote tumor cell growth, survival, and angiogenesis as a …
however, immune cells can also promote tumor cell growth, survival, and angiogenesis as a …
Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy.
L Tian, A Lei, T Tan, M Zhu, L Zhang, H Mou… - Kidney …, 2022 - search.ebscohost.com
Background: Cells of the immune system can inhibit tumor growth and progression;
however, immune cells can also promote tumor cell growth, survival, and angiogenesis as a …
however, immune cells can also promote tumor cell growth, survival, and angiogenesis as a …
Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy
L Tian, A Lei, T Tan, M Zhu, L Zhang, H Mou… - Kidney Diseases, 2022 - karger.com
Background: Cells of the immune system can inhibit tumor growth and progression;
however, immune cells can also promote tumor cell growth, survival, and angiogenesis as a …
however, immune cells can also promote tumor cell growth, survival, and angiogenesis as a …
[HTML][HTML] Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy
L Tian, A Lei, T Tan, M Zhu, L Zhang, H Mou… - Kidney …, 2022 - ncbi.nlm.nih.gov
Background Cells of the immune system can inhibit tumor growth and progression; however,
immune cells can also promote tumor cell growth, survival, and angiogenesis as a result of …
immune cells can also promote tumor cell growth, survival, and angiogenesis as a result of …
Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy.
L Tian, A Lei, T Tan, M Zhu, L Zhang… - Kidney Diseases …, 2021 - europepmc.org
Background Cells of the immune system can inhibit tumor growth and progression; however,
immune cells can also promote tumor cell growth, survival, and angiogenesis as a result of …
immune cells can also promote tumor cell growth, survival, and angiogenesis as a result of …
Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy.
L Tian, A Lei, T Tan, M Zhu, L Zhang… - Kidney Diseases …, 2021 - europepmc.org
Background Cells of the immune system can inhibit tumor growth and progression; however,
immune cells can also promote tumor cell growth, survival, and angiogenesis as a result of …
immune cells can also promote tumor cell growth, survival, and angiogenesis as a result of …